Remedies in EU Merger Control

Download IconDownload Print IconPrint

Remedies in EU Merger Control

Client News

Related Documents

Related Solutions

Our experienced team helps clients from around the globe navigate the complex world of EU law, regulation and policy.
We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.

On 24 May 2018, John Ratliff chaired and participated in a panel on “Current and Future Trends in Remedies” at the Knect365 (formerly IBC) Merger Control Conference in Brussels. 

The panel discussed: (i) increasing use of upfront buyers in EC practice; (ii) recent EU behavioural commitments to meet vertical concerns; (iii) the trend in the EU to structural remedies to deal with innovation concerns, including divestiture of R&D organisations; and (iv) how to deal with remedies in cases involving worldwide filings, with reference to AB InBev SAB Miller. The panel included David Riley from Sky, Justin Menezes from Mazars, Matthias Eisenbarth from AB InBev and John Ratliff from WilmerHale.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel